Cardiosense Raises $26.1M in Series B for AI Cardiac Monitoring Platform

Cardiosense Secures $26.1M in Series B Funding

Cardiosense, a company developing a wearable sensor and AI platform for cardiac monitoring, has raised $26.1 million in a Series B funding round, according to a filing dated August 24, 2026. The round did not list any participating investors.

The company's platform combines seismocardiogram, photoplethysmogram, and electrocardiogram signals into clinical algorithms that flag worsening heart failure before hospitalization. Cardiosense has received FDA De Novo Classification for its cardiac-monitoring technology and works with health-system and payer partners on early-warning heart failure programs.

The new funding will support the company's continued development and commercialization efforts, though specific plans were not disclosed.